# GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

> **NCT00429494** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 60 (actual)

## Conditions studied

- Amenorrhea
- Premature Ovarian Failure
- Ovarian Function Insufficiency

## Interventions

- **DRUG:** Leuprolide Acetate
- **BEHAVIORAL:** Questionnaire
- **PROCEDURE:** Hematopoietic Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00429494
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2013-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429494, "GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00429494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*